387 related articles for article (PubMed ID: 15742443)
21. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988.
Franzén P; Sutinen S; von Knorring J
J Rheumatol; 1992 Feb; 19(2):273-6. PubMed ID: 1629827
[TBL] [Abstract][Full Text] [Related]
22. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M; Dababneh A; Hajeer A; Ollier WE
J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051
[TBL] [Abstract][Full Text] [Related]
23. Geographical and genetic factors do not account for significant differences in the clinical spectrum of giant cell arteritis in southern europe.
Gonzalez-Gay MA; Boiardi L; Garcia-Porrua C; Macchioni P; Amor-Dorado JC; Salvarani C
J Rheumatol; 2004 Mar; 31(3):520-3. PubMed ID: 14994398
[TBL] [Abstract][Full Text] [Related]
24. [Giant cell arteritis. A study of 191 patients].
Armona J; Rodríguez-Valverde V; González-Gay MA; Figueroa M; Fernández-Sueiro JL; Blanco R; Martínez-Taboada V
Med Clin (Barc); 1995 Dec; 105(19):734-7. PubMed ID: 8523954
[TBL] [Abstract][Full Text] [Related]
25. [Giant-cell arteritis: a descriptive study in southwestern Spain].
Calvo Romero JM; Magro Ledesma D; Ramos Salado JL; Bureo Dacal JC; de Dios Arrebola García J; Bureo Dacal P; Pérez Miranda M
An Med Interna; 2000 Feb; 17(2):67-70. PubMed ID: 10829459
[TBL] [Abstract][Full Text] [Related]
26. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
Semin Arthritis Rheum; 2008 Oct; 38(2):116-23. PubMed ID: 18221984
[TBL] [Abstract][Full Text] [Related]
27. Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis.
Palomino-Morales R; Torres O; Vazquez-Rodriguez TR; Morado IC; Castañeda S; Callejas-Rubio JL; Miranda-Filloy JA; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
J Rheumatol; 2009 Jul; 36(7):1501-6. PubMed ID: 19531762
[TBL] [Abstract][Full Text] [Related]
28. Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients.
Hailpern SM; Cohen HW; Alderman MH
Am J Hypertens; 2006 Oct; 19(10):998-1004. PubMed ID: 17027817
[TBL] [Abstract][Full Text] [Related]
29. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.
Salvarani C; Casali B; Farnetti E; Pipitone N; Formisano D; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Grazia Catanoso M; Restuccia G; Ghinoi A; Boiardi L
Arthritis Rheum; 2007 Oct; 56(10):3502-8. PubMed ID: 17907177
[TBL] [Abstract][Full Text] [Related]
30. Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.
Catanoso M; Macchioni P; Boiardi L; Muratore F; Restuccia G; Cavazza A; Pipitone N; Mancuso P; Luberto F; Salvarani C
Arthritis Care Res (Hoboken); 2017 Mar; 69(3):430-438. PubMed ID: 27214746
[TBL] [Abstract][Full Text] [Related]
31. Temporal artery biopsy is not required in all cases of suspected giant cell arteritis.
Quinn EM; Kearney DE; Kelly J; Keohane C; Redmond HP
Ann Vasc Surg; 2012 Jul; 26(5):649-54. PubMed ID: 22285348
[TBL] [Abstract][Full Text] [Related]
32. Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients.
Esteban MJ; Font C; Hernández-Rodríguez J; Valls-Solé J; Sanmartí R; Cardellach F; García-Martínez A; Campo E; Urbano-Márquez A; Grau JM; Cid MC
Arthritis Rheum; 2001 Jun; 44(6):1387-95. PubMed ID: 11407699
[TBL] [Abstract][Full Text] [Related]
33. Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain.
Rueda B; Roibas B; Martin J; Gonzalez-Gay MA
J Rheumatol; 2007 Jul; 34(7):1535-9. PubMed ID: 17552041
[TBL] [Abstract][Full Text] [Related]
34. Epidemiological and clinical features of giant cell arteritis in Tunisia.
Khalifa M; Karmani M; Jaafoura NG; Kaabia N; Letaief AO; Bahri F;
Eur J Intern Med; 2009 Mar; 20(2):208-12. PubMed ID: 19327614
[TBL] [Abstract][Full Text] [Related]
35. Predictors of cerebrovascular accidents in giant cell arteritis in a defined population.
Pego-Reigosa R; Garcia-Porrua C; Piñeiro A; Dierssen T; Llorca J; Gonzalez-Gay MA
Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S13-7. PubMed ID: 15675128
[TBL] [Abstract][Full Text] [Related]
36. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden.
Mohammad AJ; Nilsson JÅ; Jacobsson LT; Merkel PA; Turesson C
Ann Rheum Dis; 2015 Jun; 74(6):993-7. PubMed ID: 24442881
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis.
Ponge T; Barrier JH; Grolleau JY; Ponge A; Vlasak AM; Cottin S
J Rheumatol; 1988 Jun; 15(6):997-1000. PubMed ID: 2971112
[TBL] [Abstract][Full Text] [Related]
38. Quantification of the role of temporal artery biopsy in diagnosing clinically suspected giant cell arteritis.
Varma D; O'Neill D
Eye (Lond); 2004 Apr; 18(4):384-8. PubMed ID: 15069435
[TBL] [Abstract][Full Text] [Related]
39. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
Lee MS; Smith SD; Galor A; Hoffman GS
Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic value of clinical signs in giant cell arteritis: analysis of 415 temporal artery biopsy findings].
Strady C; Arav E; Strady A; Jaussaud R; Beguinot I; Rouger C; Pluot M; Remy G
Ann Med Interne (Paris); 2002 Feb; 153(1):3-12. PubMed ID: 11994684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
